Charles Russell Speechlys advises Kreos Capital V (UK) Limited on senior secured loan to Pharming Group NV
Charles Russell Speechlys LLP advised Kreos Capital V (UK) Limited (“Kreos”) on its €21 million senior secured loan to Pharming Group NV (“Pharming”) and its subscription for €6 million subordinated redeemable convertible bond issued by Pharming.
The transaction is part of a larger fundraising exercise carried out by Pharming to raise €104 million before costs (comprising of straight debt, convertible bonds and proceeds of rights issue) to, amongst others, acquire all commercialisation rights to its own product RUCONEST® in North America and to repay its existing debt facility.
The Charles Russell Speechlys core team comprised Corporate Partner Chris Putt, Corporate Associates Rossana Conti and Amelly Kok and Banking Partner Daniel Sullivan.
News & Insights
Charles Russell Speechlys releases H2 2020 deal highlights
Our highlights over the past 6 months are now available.
Haliburton v Chubb: The final say on an arbitrator’s duty of disclosure
We consider some of the key points when appointed arbitrators do not agree on the appointment of the third arbitrator as chairman.
Understanding Rules of Origin under the Brexit Agreement
The UK-EU TCA came into effect on 31st December 2020, what does it mean for importers and exporters? and what does Rules of Origin mean?